[Evaluation of diagnostic values of neoplastic procoagulant in pancreatic, hepatic and ovary cancers].
The cancer procoagulant (CP) activity has been evaluated in serum of patients with pancreas, liver and ovarian cancer and in homogenates of these cancer tissues. CP activity in examined cancer tissues as well as in blood serum was significantly higher than in the control. The obtained results indicate that estimation of CP activity may be useful in oncological diagnosis of pancreas, liver and ovarian cancer.
Snarska
Jadwiga
J
Klinika Chirurgii Ogólnej, AM w Białymstoku.
Szajda
Sławomir
S
Skrzydlewski
Zdzisław
Z
Kozuszko
Bozena
B
D000368:Aged; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism*
D009363:Neoplasm Proteins; D003546:Cysteine Endopeptidases; C030910:cancer procoagulant